Patsy and all of the wonderful technical colleagues,
The ER guidelines are already in print, and you can download the
article from the CAP website. Yes, you are correct about the upper
fixation limit for ER, which was adopted from our consensus conference
that included a number of experienced scientists (Yaziji H, et al.
Applied Immunohistochemistry Dec 2008).
Regarding HER2 guidelines, DO NOT CHANGE YOUR TECHNICAL STAFF SCHEDULE
YET. The panel is meeting now to deliberate on increasing the upper
limit of fixation for HER2 to 72 hours. We are pushing hard on this,
but 1/2 of the panel is made of medical oncologists who do not know
much about tissue fixation.
Once the changes are made, I promise to share the news with the groups
first thing if they don't get it through CAP publication.
Hadi
================================
Hadi Yaziji, M.D., Medical Director
Vitro Molecular Laboratories
President,
Ancillary Pathways
7000 62nd Avenue, PH-C
Miami, FL 33143
T 305-740-4440
F. 786-513-0175
www.vitromolecular.com
www.ancillarypath.com
On Apr 26, 2010, at 12:46 PM, Patsy Ruegg wrote:
Did I understand correctly from Dr. Hammond in Florida that the ER
ASCO/CAP guidelines extended the fixation time to 72 hours? Are
they changing the Her2 guidelines to match the ER? If so, has that
happened yet? I have people very anxious to stop having techs work
on the weekends to comply with the 48 hour fixation limits.
Thank you,
Patsy
Patsy Ruegg, HT(ASCP)QIHC
IHCtech, LLC
Fitzsimmons BioScience Park
12635 Montview Blvd. Suite 215
Aurora, CO 80010
P-720-859-4060
F-720-859-4110
wk email pru...@ihctech.net
web site www.ihctech.net
This email is confidential and intended solely for the use of the
Person(s) ('the intended recipient') to whom it was addressed. Any
views or opinions presented are solely those of the author. It may
contain information that is privileged & confidential within the
meaning of applicable law. Accordingly any dissemination,
distribution, copying, or other use of this message, or any of its
contents, by any person other than the intended recipient may
constitute a breach of civil or criminal law and is strictly
prohibited. If you are NOT the intended recipient please contact the
sender and dispose of this e-mail as soon as possible.
From: ih...@googlegroups.com [mailto:ih...@googlegroups.com] On
Behalf Of Van Eyck, Deb
Sent: Monday, April 26, 2010 10:30 AM
To: ancillaryp...@mac.com; ihcrg Group (E-mail); histonet netserver
Subject: RE: [IHCRG] ER clone 1D5 or SP1 ?
This is a great discussion lets also talk about PR clones since the
ASCO/CAP guidelines just came out ------Hadi or Rich I know they
only list two PR clones one is Dako 1294-----what is the other 312?
Deb
From: ih...@googlegroups.com [mailto:ih...@googlegroups.com] On
Behalf Of ancillaryp...@mac.com
Sent: Sunday, April 25, 2010 7:36 PM
To: ihcrg Group (E-mail); histonet netserver
Subject: Re: [IHCRG] ER clone 1D5 or SP1 ?
When we started our lab 3 years ago, we began with SP1 from day 1,
so I don't have any experience with either 1D5 or 6F11 except in my
previous labs. 1D5 is an excellent clone, and seems to be more
specific than SP1 in the work-up of metastatic carcinoma of unknown
primary site, based on the published literature. The advantage of
6F11 is that, for those of us who use the Allred scoring system,
it's the only clone that was clinically validated by Harvey et al.
(JCO 1999) for this purpose. I agree with Rich.
For those who use SP1, it's a very good clone as a predictive marker
in breast cancer. But again, in the setting of metastatic workup, it
is NOT recommended, as it will pick up too many primary lung cancers
and some colon cancers (personal experience).
Hadi
================================
Hadi Yaziji, M.D., Medical Director
Vitro Molecular Laboratories
President,
Ancillary Pathways
7000 62nd Avenue, PH-C
Miami, FL 33143
T 305-740-4440
F. 786-513-0175
www.vitromolecular.com
www.ancillarypath.com
On Apr 25, 2010, at 3:04 PM, Richard Cartun wrote:
I have looked at several clones over the years and I prefer clone
6F11.
Richard
Richard W. Cartun, Ph.D.
Director, Histology & Immunopathology
Director, Biospecimen Collection Programs
Assistant Director, Anatomic Pathology
Hartford Hospital
80 Seymour Street
Hartford, CT 06102
(860) 545-1596 Office
(860) 545-2204 Fax
"Taylor, Jean" <jtay...@meriter.com> 4/23/2010 11:17 AM >>>
I'm wondering which clone of ER most labs are using?
Thanks,
Jean Taylor, HT(ASCP)QIHC
IHC Tech
Meriter Health Services
Madison, WI
--
Subscription settings: http://groups.google.com/group/ihcrg/subscribe?hl=en
This information is confidential and intended solely for the use of
the individual or entity to whom it is addressed. If you have
received this email in error please notify the sender or our
Customer Support Center at (262) 928-2777. We have scanned this e-
mail and its attachments for malicious content. However, the
recipient should check this email and any attachments for the
presence of viruses. ProHealth Care accepts no liability for any
damage caused by any virus transmitted by this email.
_______________________________________________
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet
